| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
|
14,497 |
12,144 |
$528K |
| 87635 |
|
2,951 |
2,729 |
$150K |
| 87804 |
|
5,953 |
2,802 |
$79K |
| 87880 |
|
3,945 |
3,729 |
$52K |
| 87811 |
|
705 |
663 |
$28K |
| 96372 |
|
1,071 |
1,003 |
$12K |
| 90460 |
|
872 |
404 |
$7K |
| 99391 |
|
123 |
123 |
$6K |
| 99392 |
|
113 |
113 |
$5K |
| 99393 |
|
62 |
61 |
$4K |
| 99429 |
|
150 |
150 |
$3K |
| 87807 |
|
237 |
224 |
$3K |
| 99203 |
|
41 |
40 |
$2K |
| 99000 |
|
161 |
146 |
$2K |
| 81002 |
|
533 |
508 |
$2K |
| 96110 |
|
239 |
237 |
$1K |
| 99394 |
|
14 |
14 |
$930.40 |
| 17000 |
|
12 |
12 |
$670.20 |
| 90461 |
|
171 |
151 |
$630.38 |
| 94640 |
|
37 |
37 |
$441.98 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
644 |
631 |
$368.21 |
| 17003 |
|
12 |
12 |
$67.32 |
| 90672 |
|
91 |
91 |
$24.05 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$0.36 |
| 90680 |
|
74 |
74 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
14 |
14 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
46 |
41 |
$0.00 |
| A7016 |
Dome and mouthpiece, used with small volume ultrasonic nebulizer |
37 |
37 |
$0.00 |
| 92551 |
|
103 |
101 |
$0.00 |
| 90677 |
|
107 |
107 |
$0.00 |
| 90698 |
|
16 |
16 |
$0.00 |
| 90744 |
|
46 |
46 |
$0.00 |
| 90700 |
|
94 |
94 |
$0.00 |
| 94664 |
|
25 |
25 |
$0.00 |
| 96160 |
|
14 |
14 |
$0.00 |
| 90633 |
|
34 |
34 |
$0.00 |
| 90713 |
|
74 |
74 |
$0.00 |
| 99173 |
|
103 |
101 |
$0.00 |
| 90648 |
|
74 |
74 |
$0.00 |